SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-23-000063
Filing Date
2023-06-01
Accepted
2023-06-01 16:35:00
Documents
17
Period of Report
2023-06-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20230601.htm   iXBRL 8-K 37589
2 EX-99.1 a2023_prx0601xascoposter.htm EX-99.1 12875
7 a2023_prx0601xascoposter001.jpg GRAPHIC 264324
8 a2023_prx0601xascoposter002.jpg GRAPHIC 233019
9 a2023_prx0601xascoposter003.jpg GRAPHIC 248032
  Complete submission text file 0001599298-23-000063.txt   1252621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20230601.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20230601_def.xml EX-101.DEF 15283
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20230601_lab.xml EX-101.LAB 29621
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20230601_pre.xml EX-101.PRE 15940
11 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20230601_htm.xml XML 11117
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 23985243
SIC: 2834 Pharmaceutical Preparations